AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2025

Aug 19, 2025

30071_dirs_2025-08-19_48ede664-963d-4a9b-80a4-cb0ef705df49.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-08-15

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-15	ResMed Common Stock	A	5462	—	Acquired	88745	Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 20, 2024. The shares were earned on August 15, 2025, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3
each year on the anniversary of the grant.